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Primum non nocere: 
a call for balance when 
reporting on CTE
As clinicians and researchers 
in traumatic brain injury and 
neurodegeneration, we are concerned 
by the tone of reporting on chronic 
traumatic encephalopathy (CTE) that 
has developed over the past decade, 
highlighted in an article in The New York 
Times.1 Misleading reporting can have 
unintended, negative consequences 
and we call for balance from the 
medical and scientific communities 
and the media when communicating 
on issues related to CTE. 
Contrary to common perception, the 
clinical syndrome of CTE has not yet 
been fully defined,2 its prevalence is 
unknown, and the neuropathological 
diagnostic criteria are no more than 
preliminary.3 We have an incomplete 
understanding of the extent or 
distribution of pathology required to 
produce neurological dysfunction or 
to distinguish diseased from healthy 
tissue, with the neuropathological 
changes of CTE reported in apparently 
asymptomatic individuals.4,5 Although 
commonly quoted, no consensus 
agreement has been reached on 
staging the severity of CTE pathology. 
A single focus of the pathology 
implicated in CTE is not yet sufficient 
evidence to define disease. 
Recognising limitations of the 
diagnostic process in human 
pathology, pathologists are careful to 
note that they are merely providing 
an opinion, and acknowledging that 
another pathologist might reasonably 
reach a different conclusion on the 
same case.6 In diagnoses where the 
criteria for assessment and reporting 
are established by broad consensus, 
the expectation is that variance in 
opinion is minimised. However, at this 
time, although CTE diagnostic criteria 
are far from established, discordance 
in opinions on individual cases is to be 
expected.1
Unfortunately, the uncertainties 
around the clinical syndrome and the 
pathological definition of CTE are not 
acknowledged adequately in much 
of the current research literature or 
related media reporting, which at 
times has resembled science by press 
conference.7 Too often an inaccurate 
impression is portrayed that CTE is 
clinically defined, its prevalence is 
high, and pathology evaluation is a 
simple positive or negative decision. 
This distorted reporting on CTE might 
have dire consequences. Specifically, 
individuals with potentially treatable 
conditions, such as depression or 
post-traumatic stress disorder, might 
make decisions on their future on 
the basis of a misplaced belief that 
their symptoms inevitably herald 
an untreatable, degenerative brain 
disease culminating in dementia.
We propose that the principle of 
first, to do no harm is used when 
communicating on CTE, whatever 
the platform. In particular, the many 
remaining uncertainties should always 
be acknowledged. Otherwise, the risk 
of doing harm is very real.
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